rs2230804
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000370397.8(CHUK):c.802G>A(p.Val268Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.51 in 1,605,460 control chromosomes in the GnomAD database, including 213,829 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000370397.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHUK | NM_001278.5 | c.802G>A | p.Val268Ile | missense_variant | 9/21 | ENST00000370397.8 | NP_001269.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHUK | ENST00000370397.8 | c.802G>A | p.Val268Ile | missense_variant | 9/21 | 1 | NM_001278.5 | ENSP00000359424 | P1 |
Frequencies
GnomAD3 genomes AF: 0.563 AC: 85443AN: 151848Hom.: 25155 Cov.: 31
GnomAD3 exomes AF: 0.474 AC: 118957AN: 251076Hom.: 29579 AF XY: 0.468 AC XY: 63453AN XY: 135722
GnomAD4 exome AF: 0.504 AC: 732639AN: 1453494Hom.: 188638 Cov.: 33 AF XY: 0.499 AC XY: 360835AN XY: 723620
GnomAD4 genome AF: 0.563 AC: 85532AN: 151966Hom.: 25191 Cov.: 31 AF XY: 0.557 AC XY: 41328AN XY: 74254
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 74% of patients studied by a panel of primary immunodeficiencies. Number of patients: 70. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at